AVDL Annual Total Expenses
$165.81 M
+$70.60 M+74.14%
31 December 2023
Summary:
As of January 23, 2025, AVDL annual total expenses is $165.81 million, with the most recent change of +$70.60 million (+74.14%) on December 31, 2023. During the last 3 years, it has risen by +$106.82 million (+181.06%). AVDL annual total expenses is now at all-time high.AVDL Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVDL Quarterly Total Expenses
$50.35 M
-$3.89 M-7.18%
30 September 2024
Summary:
As of January 23, 2025, AVDL quarterly total expenses is $50.35 million, with the most recent change of -$3.89 million (-7.18%) on September 30, 2024. Over the past year, it has increased by +$6.00 million (+13.53%). AVDL quarterly total expenses is now -7.18% below its all-time high of $54.24 million, reached on June 30, 2024.AVDL Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVDL Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +74.1% | +13.5% |
| 3 y3 years | +181.1% | -1.3% |
| 5 y5 years | +1.2% | -1.3% |
AVDL Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.7% | -7.2% | +195.7% |
| 5 y | 5-year | at high | +181.1% | -7.2% | +259.9% |
| alltime | all time | at high | +1092.9% | -7.2% | +885.5% |
Avadel Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $50.35 M(-7.2%) |
| June 2024 | - | $54.24 M(+1.9%) |
| Mar 2024 | - | $53.21 M(+20.0%) |
| Dec 2023 | $165.81 M(+74.1%) | $44.35 M(+5.3%) |
| Sept 2023 | - | $42.12 M(-17.5%) |
| June 2023 | - | $51.04 M(+80.4%) |
| Mar 2023 | - | $28.30 M(+21.9%) |
| Dec 2022 | $95.22 M(+11.2%) | $23.22 M(+36.3%) |
| Sept 2022 | - | $17.03 M(-35.4%) |
| June 2022 | - | $26.34 M(-8.0%) |
| Mar 2022 | - | $28.63 M(+23.7%) |
| Dec 2021 | $85.60 M(+45.1%) | $23.14 M(-9.8%) |
| Sept 2021 | - | $25.66 M(+17.0%) |
| June 2021 | - | $21.94 M(+47.6%) |
| Mar 2021 | - | $14.86 M(+4.2%) |
| Dec 2020 | $58.99 M(-22.4%) | $14.26 M(+1.9%) |
| Sept 2020 | - | $13.99 M(-4.4%) |
| June 2020 | - | $14.64 M(-9.1%) |
| Mar 2020 | - | $16.10 M(-10.7%) |
| Dec 2019 | $76.04 M(-53.6%) | $18.04 M(+13.6%) |
| Sept 2019 | - | $15.88 M(-23.9%) |
| June 2019 | - | $20.88 M(-1.7%) |
| Mar 2019 | - | $21.24 M(-39.7%) |
| Dec 2018 | $163.82 M(+46.0%) | $35.20 M(-14.1%) |
| Sept 2018 | - | $40.97 M(-8.7%) |
| June 2018 | - | $44.85 M(+4.8%) |
| Mar 2018 | - | $42.80 M(+5.9%) |
| Dec 2017 | $112.24 M(+6.0%) | $40.40 M(+68.2%) |
| Sept 2017 | - | $24.01 M(-1.4%) |
| June 2017 | - | $24.35 M(+3.7%) |
| Mar 2017 | - | $23.48 M(-21.0%) |
| Dec 2016 | $105.93 M(+48.6%) | $29.73 M(+8.4%) |
| Sept 2016 | - | $27.43 M(+3.5%) |
| June 2016 | - | $26.50 M(+19.0%) |
| Mar 2016 | - | $22.27 M(+23.4%) |
| Dec 2015 | $71.29 M(+48.1%) | $18.05 M(+6.1%) |
| Sept 2015 | - | $17.02 M(-10.3%) |
| June 2015 | - | $18.97 M(+9.9%) |
| Mar 2015 | - | $17.26 M(+1632.7%) |
| Dec 2014 | $48.13 M(+61.8%) | $996.00 K(-93.8%) |
| Sept 2014 | - | $15.98 M(+43.9%) |
| June 2014 | - | $11.11 M(-0.5%) |
| Mar 2014 | - | $11.17 M(-327.7%) |
| Dec 2013 | $29.74 M(+2.2%) | -$4.91 M(-143.3%) |
| Sept 2013 | - | $11.34 M(+0.4%) |
| June 2013 | - | $11.29 M(-6.0%) |
| Mar 2013 | - | $12.02 M(-287.4%) |
| Dec 2012 | $29.11 M | -$6.41 M(-159.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $10.85 M(-10.9%) |
| June 2012 | - | $12.18 M(-2.4%) |
| Mar 2012 | - | $12.49 M(+14.3%) |
| Dec 2011 | $42.18 M(-10.1%) | $10.93 M(+18.8%) |
| Sept 2011 | - | $9.19 M(-11.7%) |
| June 2011 | - | $10.41 M(-10.7%) |
| Mar 2011 | - | $11.65 M(+2.2%) |
| Dec 2010 | $46.93 M(-12.9%) | $11.41 M(+2.1%) |
| Sept 2010 | - | $11.17 M(-8.8%) |
| June 2010 | - | $12.24 M(+1.0%) |
| Mar 2010 | - | $12.12 M(-26.7%) |
| Dec 2009 | $53.87 M(+4.0%) | $16.53 M(+24.9%) |
| Sept 2009 | - | $13.24 M(+0.3%) |
| June 2009 | - | $13.19 M(+20.9%) |
| Mar 2009 | - | $10.91 M(+47.4%) |
| Dec 2008 | $51.80 M(-33.2%) | $7.40 M(-46.2%) |
| Sept 2008 | - | $13.75 M(-7.6%) |
| June 2008 | - | $14.89 M(-5.5%) |
| Mar 2008 | - | $15.76 M(-15.4%) |
| Dec 2007 | $77.50 M(+25.3%) | $18.62 M(+1.8%) |
| Sept 2007 | - | $18.28 M(-14.8%) |
| June 2007 | - | $21.46 M(+12.1%) |
| Mar 2007 | - | $19.14 M(+17.8%) |
| Dec 2006 | $61.86 M(-3.9%) | $16.25 M(+1.2%) |
| Sept 2006 | - | $16.05 M(+12.1%) |
| June 2006 | - | $14.32 M(-6.0%) |
| Mar 2006 | - | $15.24 M(-12.2%) |
| Dec 2005 | $64.37 M(+38.2%) | $17.35 M(+13.6%) |
| Sept 2005 | - | $15.27 M(-4.9%) |
| June 2005 | - | $16.06 M(+2.4%) |
| Mar 2005 | - | $15.69 M(+14.5%) |
| Dec 2004 | $46.58 M(+55.9%) | $13.70 M(+22.0%) |
| Sept 2004 | - | $11.23 M(+1.4%) |
| June 2004 | - | $11.08 M(+4.8%) |
| Mar 2004 | - | $10.57 M(-38.5%) |
| Dec 2003 | $29.87 M(+60.3%) | $17.18 M(+154.8%) |
| Sept 2003 | - | $6.74 M(0.0%) |
| June 2003 | - | $6.74 M(+13.3%) |
| Mar 2003 | - | $5.95 M(+0.5%) |
| Dec 2002 | $18.63 M(+14.7%) | $5.92 M(+43.2%) |
| Sept 2002 | - | $4.13 M(-17.3%) |
| Dec 2001 | $16.24 M(-39.9%) | - |
| Dec 2000 | $27.01 M(+49.7%) | - |
| Dec 1999 | $18.04 M(-4.1%) | - |
| Dec 1998 | $18.81 M(+10.0%) | - |
| Mar 1998 | - | $5.00 M(+56.3%) |
| Dec 1997 | $17.10 M(+23.0%) | - |
| Dec 1996 | $13.90 M | - |
| Mar 1996 | - | $3.20 M |
FAQ
- What is Avadel Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual total expenses year-on-year change?
- What is Avadel Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly total expenses year-on-year change?
What is Avadel Pharmaceuticals annual total expenses?
The current annual total expenses of AVDL is $165.81 M
What is the all time high annual total expenses for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual total expenses is $165.81 M
What is Avadel Pharmaceuticals annual total expenses year-on-year change?
Over the past year, AVDL annual total expenses has changed by +$70.60 M (+74.14%)
What is Avadel Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of AVDL is $50.35 M
What is the all time high quarterly total expenses for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly total expenses is $54.24 M
What is Avadel Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, AVDL quarterly total expenses has changed by +$6.00 M (+13.53%)